Astrazeneca Pharma India standalone net profit declines 66.65% in the September 2018 quarter
Sales decline 1.77% to Rs 161.36 crore
Net profit of Astrazeneca Pharma India declined 66.65% to Rs 9.13 crore in the quarter ended September 2018 as against Rs 27.38 crore during the previous quarter ended September 2017. Sales declined 1.77% to Rs 161.36 crore in the quarter ended September 2018 as against Rs 164.26 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales161.36164.26 -2 OPM %9.1521.70 -PBDT18.1138.14 -53 PBT14.4434.39 -58 NP9.1327.38 -67Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2018 | 4:20 PM IST